DK1216046T3 - Hidtil ukendt kombination af loteprednol og antihistaminer - Google Patents

Hidtil ukendt kombination af loteprednol og antihistaminer

Info

Publication number
DK1216046T3
DK1216046T3 DK00969303T DK00969303T DK1216046T3 DK 1216046 T3 DK1216046 T3 DK 1216046T3 DK 00969303 T DK00969303 T DK 00969303T DK 00969303 T DK00969303 T DK 00969303T DK 1216046 T3 DK1216046 T3 DK 1216046T3
Authority
DK
Denmark
Prior art keywords
loteprednol
antihistamines
hitherto unknown
unknown combination
combination
Prior art date
Application number
DK00969303T
Other languages
English (en)
Inventor
Istvan Szelenyi
Degenhard Marx
Sabine Heer
Juergen Engel
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Application granted granted Critical
Publication of DK1216046T3 publication Critical patent/DK1216046T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK00969303T 1999-09-30 2000-09-26 Hidtil ukendt kombination af loteprednol og antihistaminer DK1216046T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947234A DE19947234A1 (de) 1999-09-30 1999-09-30 Neue Kombination von Loteprednol und Antihistaminika
PCT/EP2000/009391 WO2001022955A2 (de) 1999-09-30 2000-09-26 Neue kombination von loteprednol und antihistaminika

Publications (1)

Publication Number Publication Date
DK1216046T3 true DK1216046T3 (da) 2003-09-29

Family

ID=7924100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00969303T DK1216046T3 (da) 1999-09-30 2000-09-26 Hidtil ukendt kombination af loteprednol og antihistaminer

Country Status (19)

Country Link
US (1) US7022687B1 (da)
EP (1) EP1216046B1 (da)
JP (2) JP5524438B2 (da)
AR (1) AR025923A1 (da)
AT (1) ATE241988T1 (da)
AU (1) AU7907300A (da)
BR (1) BR0014312B1 (da)
CA (1) CA2387398C (da)
CZ (1) CZ295090B6 (da)
DE (2) DE19947234A1 (da)
DK (1) DK1216046T3 (da)
EE (1) EE04997B1 (da)
ES (1) ES2199868T3 (da)
HU (1) HU229606B1 (da)
MX (1) MXPA02003174A (da)
PL (1) PL196843B1 (da)
PT (1) PT1216046E (da)
TW (1) TWI224968B (da)
WO (1) WO2001022955A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0214643A (pt) * 2001-12-05 2004-11-03 Alcon Inc Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
EP2295062B1 (en) 2002-08-30 2012-08-29 Nycomed GmbH The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
JP2006508138A (ja) * 2002-11-12 2006-03-09 アルコン，インコーポレイテッド アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用
DE60323138D1 (de) 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2005094836A2 (en) * 2004-03-25 2005-10-13 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
BR112013017183A2 (pt) 2011-01-04 2017-07-25 Bausch & Lomb composições de bepostatina
JP2015518006A (ja) * 2012-05-25 2015-06-25 エクスクリア インコーポレイテッド キシリトール系の抗粘膜組成物及び関連する方法並びに組成物
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
AU6392496A (en) * 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
JP4453987B2 (ja) * 1997-01-16 2010-04-21 千寿製薬株式会社 点鼻用水性懸濁液

Also Published As

Publication number Publication date
BR0014312A (pt) 2002-05-21
AU7907300A (en) 2001-04-30
CZ295090B6 (cs) 2005-05-18
EE04997B1 (et) 2008-04-15
EP1216046A2 (de) 2002-06-26
EP1216046B1 (de) 2003-06-04
WO2001022955A3 (de) 2001-05-17
PL196843B1 (pl) 2008-02-29
CZ20021014A3 (cs) 2002-06-12
CA2387398A1 (en) 2002-03-28
US7022687B1 (en) 2006-04-04
ATE241988T1 (de) 2003-06-15
AR025923A1 (es) 2002-12-18
PT1216046E (pt) 2003-10-31
BR0014312B1 (pt) 2012-09-04
PL353486A1 (en) 2003-11-17
EE200200146A (et) 2003-04-15
CA2387398C (en) 2009-05-12
WO2001022955A2 (de) 2001-04-05
HUP0202862A3 (en) 2003-10-28
JP2012001558A (ja) 2012-01-05
DE19947234A1 (de) 2001-04-05
TWI224968B (en) 2004-12-11
MXPA02003174A (es) 2003-08-20
HU229606B1 (en) 2014-02-28
JP5524438B2 (ja) 2014-06-18
DE50002478D1 (de) 2003-07-10
ES2199868T3 (es) 2004-03-01
JP2003510275A (ja) 2003-03-18
HUP0202862A2 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
DK1216046T3 (da) Hidtil ukendt kombination af loteprednol og antihistaminer
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DE10080052T1 (de) Beratungshilfeverfahren und -einrichtungen
NO20022334L (no) Ny sammensetning og anvendelse
NO20032753D0 (no) Forbindelse og anvendelse derav
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
DK1578771T3 (da) Remodellering og glycokonjugering af peptider
NO20022656L (no) Caspaseinhibitorer og anvendelse derav
DE60142978D1 (de) Chirurgisches zugangsgerät und -verfahren
NO20041272L (no) Tetracycline derivatives and methods of use thereof
FR17C1053I2 (fr) Remodelage et glycoconjugation de facteur ix
DK1212317T3 (da) Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DE60122160D1 (de) Antennenstruktur und zugehöriges verfahren
DK1355936T3 (da) Polymerkonjugater af neublastin og fremgangsmåder til anvendelse af samme
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
DE50009766D1 (de) Befestigungs- und Fixierungsvorrichtung
DK0994706T3 (da) Præparater til oral indgivelse af taxaner og anvendelse deraf
DE50003755D1 (de) Satz von schmuckstücken
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
DK1390516T3 (da) Hidtil ukendte ekspressionsvektorer og anvendelser deraf
DK1272456T3 (da) Angioneseinhibitorer på basis af hydrazid og alkoxyamid